Clinical Trials in Salt Lake City

Showing 9821-9840 of 16,694 trials

A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer

NCT02059213

This study will look at the effect of adding the drug Palbociclib to CAD (Combined Androgen Deprivation) therapy in patients with RB (Retinoblastoma Protein) positive hormone sensitive prostate cancer. The investigators hypothesize that the addition of Palbociclib to initial ADT (Androgen Deprivation Therapy) in patients with newly metastatic RB-positive prostate cancer may significantly increase the efficacy of ADT.

Prostate Cancer

University of Michigan Rogel Cancer Center72 participantsStarted Jun 2014

Duarte, California, United States • Chicago, Illinois, United States • Baltimore, Maryland, United States +5 more locations

COMPLETEDPhase 2< 1 mile

Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery

NCT03212365

Plastic and reconstructive surgeons consistently create large, raw surfaces as part of their operative procedures. Thus, plastic \& reconstructive surgery patients are among those at highest risk for anticoagulant-associated bleeding adverse drug events (ADEs). This study seeks to optimize both the safety and effectiveness of post-operative enoxaparin by comparing aFXa levels, bleeding events, and VTE events among plastic \& reconstructive surgery patients randomized to receive two different enoxaparin dose regimens.

Venous ThromboembolismDeep Venous ThrombosisPulmonary Embolus+1 more

University of Utah295 participantsStarted Jul 2017

Stanford, California, United States • Salt Lake City, Utah, United States

A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer

Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery

Find Trials by Condition in Salt Lake City

Comparison of Quantitative MRI Perfusion Methods With Quantitative PET Perfusion Imaging

Oral Iron for Erythropoietic Protoporphyrias

Behavioral Therapy Of Obstetric Sphincter Tears

Clinical Evaluation of Flortaucipir F 18

Dose Finding Study to Treat High Phosphate Levels in the Blood.

A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer

Phase Ib/II Study of M3814 With Etoposide and Cisplatin in Small Cell Lung Cancer (SCLC) Extensive Disease (ED)

PROMINENT-Eye Ancillary Study (Protocol AD)

A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC)

A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer

Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer

Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis

A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma

Multidimensional System to Dynamically Predict Graft Survival After Kidney Transplantation

Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma

Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis

Electric-Acoustic Stimulation Extended Follow-up Post Approval Study